Please login to the form below

Not currently logged in
Email:
Password:

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

Fumie GriegoGlobal pharma association the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has appointed Femie Griego to be its new assistant director general.

She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA).

Prior to that Griego spent time at the White House as its senior economist where she provided US officials in both the Bush and Obama administrations with advice on a range of health and policy issues.

Thomas Cueni, director-general at IFPMA, said: “I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.

“She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”

Griego will join IFPMA's leadership team and will also be working on strengthening the association's work on the industry’s value proposition.

11th May 2017

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...